Help | RSS Feed

Mateon Therapeutics, Inc. (OTCMKT:MATN) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Mateon Therapeutics, Inc. (OTCMKT:MATN) seasonal charts above shows that a Buy Date of January 1 and a Sell Date of March 31 has resulted in a geometric average return of 2.62% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 102.62% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Mateon Therapeutics Inc is an oncology company focusing on therapies against cancers and infectious diseases. It has three business segments namely, PointR; Mateon/Oxigene; and Oncotelic. PointR is the developer of vision grid/cluster computing/AI to support drug development. Mateon/Oxigene develops a Vascular Disrupting Agent (CA4P and Oxi4503). FDA granted CA4P rare pediatric designation for pediatric melanoma and OXi4503 rare pediatric designation for pediatric ALL. Oncotelic consists development of OT-101 – antisense against TGF-beta- for the treatment of cancers. OT-101 completed phase 2 against pancreatic cancer, glioblastoma, and melanoma. The firm is also developing Artemisinin which is approved by India and in phase 4 clinical trial against COVID.

To download MATN seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z